Kemal Yelekçi

2.0k total citations · 1 hit paper
66 papers, 1.6k citations indexed

About

Kemal Yelekçi is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Kemal Yelekçi has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 32 papers in Organic Chemistry and 14 papers in Pharmacology. Recurrent topics in Kemal Yelekçi's work include Synthesis and biological activity (18 papers), Histone Deacetylase Inhibitors Research (14 papers) and Click Chemistry and Applications (14 papers). Kemal Yelekçi is often cited by papers focused on Synthesis and biological activity (18 papers), Histone Deacetylase Inhibitors Research (14 papers) and Click Chemistry and Applications (14 papers). Kemal Yelekçi collaborates with scholars based in Türkiye, Nigeria and United States. Kemal Yelekçi's co-authors include Ammar D. Elmezayen, Abdullahi İbrahim Uba, Gülberk Uçar, Gamze Bora, Hayat Erdem‐Yurter, Sevim Dalkara, Didem Dayangaç Erden, Ayhan S. Demir, Nesrin Gökhan-Kelekçi and Safiye Sağ Erdem and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Biochemistry.

In The Last Decade

Kemal Yelekçi

62 papers receiving 1.6k citations

Hit Papers

Drug repurposing for coronavirus (COVID-19): in silico sc... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
    2020 288 citations Ammar D. Elmezayen, Kemal Yelekçi et al. Journal of Biomolecular Structure and Dynamics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kemal Yelekçi Türkiye 22 696 678 471 270 221 66 1.6k
Venkatesan Jayaprakash India 30 748 1.1× 1.1k 1.6× 310 0.7× 456 1.7× 240 1.1× 122 2.3k
Simona Distinto Italy 30 1.5k 2.1× 1.1k 1.6× 668 1.4× 420 1.6× 440 2.0× 83 2.7k
Elias Maccioni Italy 30 1.1k 1.6× 1.2k 1.7× 158 0.3× 349 1.3× 390 1.8× 99 2.4k
Giosuè Costa Italy 30 1.4k 2.0× 388 0.6× 220 0.5× 307 1.1× 433 2.0× 107 2.5k
Giulio Poli Italy 27 1.2k 1.7× 518 0.8× 478 1.0× 424 1.6× 131 0.6× 98 2.0k
Manjunath Ghate India 25 857 1.2× 1.0k 1.5× 392 0.8× 272 1.0× 192 0.9× 97 2.1k
Andrea Tafi Italy 30 802 1.2× 1.1k 1.7× 192 0.4× 263 1.0× 171 0.8× 85 2.1k
Xerardo García‐Mera Spain 24 918 1.3× 922 1.4× 652 1.4× 215 0.8× 120 0.5× 147 1.9k
Rajani Giridhar India 26 542 0.8× 782 1.2× 300 0.6× 276 1.0× 88 0.4× 97 1.6k
Antonio Carrieri Italy 25 827 1.2× 744 1.1× 284 0.6× 354 1.3× 121 0.5× 99 1.8k

Countries citing papers authored by Kemal Yelekçi

Since Specialization
Citations

This map shows the geographic impact of Kemal Yelekçi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Yelekçi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Yelekçi more than expected).

Fields of papers citing papers by Kemal Yelekçi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Yelekçi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Yelekçi. The network helps show where Kemal Yelekçi may publish in the future.

Co-authorship network of co-authors of Kemal Yelekçi

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Yelekçi. A scholar is included among the top collaborators of Kemal Yelekçi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Yelekçi. Kemal Yelekçi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Erdoğan, Ömer, et al.. (2023). Novel azole-urea hybrids as VEGFR-2 inhibitors: Synthesis, in vitro antiproliferative evaluation and in silico studies. Journal of Molecular Structure. 1294. 136448–136448. 8 indexed citations
3.
Yelekçi, Kemal, et al.. (2023). Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen. Journal of Molecular Structure. 1289. 135876–135876. 1 indexed citations
4.
Ding, Kai, Chang‐Guo Zhan, Kemal Yelekçi, et al.. (2022). Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity. Molecular Diversity. 27(5). 2185–2215. 6 indexed citations
5.
Uba, Abdullahi İbrahim, et al.. (2021). Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling. Molecular Diversity. 26(2). 1005–1016. 3 indexed citations
6.
Salgin-Goksen, U., et al.. (2021). New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors. Journal of Medicinal Chemistry. 64(4). 1989–2009. 29 indexed citations
7.
Elmezayen, Ammar D. & Kemal Yelekçi. (2021). Structure-based virtual screening for novel potential selective inhibitors of class IIa histone deacetylases for cancer treatment. Computational Biology and Chemistry. 92. 107491–107491. 8 indexed citations
8.
Elmezayen, Ammar D. & Kemal Yelekçi. (2020). Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes. Journal of Biomolecular Structure and Dynamics. 39(17). 6396–6414. 87 indexed citations
9.
Elmezayen, Ammar D., et al.. (2020). Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure and Dynamics. 39(8). 2980–2992. 288 indexed citations breakdown →
10.
Yıldırım, Yeliz, H. Yeşim Karasulu, Ercüment Karasulu, et al.. (2020). Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives. European Journal of Medicinal Chemistry. 208. 112841–112841. 25 indexed citations
11.
Elmezayen, Ammar D., et al.. (2020). Homology modeling of human GABA-AT and devise some novel and potent inhibitors via computer-aided drug design techniques. Journal of Biomolecular Structure and Dynamics. 39(11). 4100–4110. 15 indexed citations
12.
Uba, Abdullahi İbrahim & Kemal Yelekçi. (2019). Crystallographic structure versus homology model: a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10. Journal of Biomolecular Structure and Dynamics. 38(15). 4397–4406. 14 indexed citations
13.
Uba, Abdullahi İbrahim & Kemal Yelekçi. (2018). Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6. Computational Biology and Chemistry. 77. 318–330. 18 indexed citations
14.
Uba, Abdullahi İbrahim & Kemal Yelekçi. (2018). Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies. Computational Biology and Chemistry. 75. 131–142. 18 indexed citations
15.
Çevik, Özge, et al.. (2018). Synthesis, anticancer activity, and molecular modeling of etodolac‐thioether derivatives as potent methionine aminopeptidase (type II) inhibitors. Archiv der Pharmazie. 351(3-4). e1700195–e1700195. 22 indexed citations
16.
Gökhan-Kelekçi, Nesrin, Ömer Şimşek, Ayşe Ercan, et al.. (2009). Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Bioorganic & Medicinal Chemistry. 17(18). 6761–6772. 33 indexed citations
17.
Bora, Gamze, Didem Dayangaç Erden, Ayhan S. Demir, et al.. (2009). Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bioorganic & Medicinal Chemistry. 17(14). 5219–5228. 138 indexed citations
18.
Erdem, Safiye Sağ, et al.. (2007). Thermal rearrangement of 2-acetoxy-2,6,6-trimethylbicyclo[3.1.0]hexane: Theoretical elucidation of the mechanism. Journal of Molecular Structure THEOCHEM. 814(1-3). 61–73. 2 indexed citations
19.
Erdem, Safiye Sağ, Özlem Karahan, İbrahim Yıldız, & Kemal Yelekçi. (2006). A computational study on the amine-oxidation mechanism of monoamine oxidase: Insight into the polar nucleophilic mechanism. Organic & Biomolecular Chemistry. 4(4). 646–646. 50 indexed citations
20.
Yelekçi, Kemal, et al.. (2005). Docking studies on monoamine oxidase-B inhibitors: Estimation of inhibition constants (Ki) of a series of experimentally tested compounds. Bioorganic & Medicinal Chemistry Letters. 15(20). 4438–4446. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Venkatesan Jayaprakash Breakdown of academic impact, for papers by Simona Distinto Breakdown of academic impact, for papers by Elias Maccioni Breakdown of academic impact, for papers by Giosuè Costa Breakdown of academic impact, for papers by Giulio Poli Breakdown of academic impact, for papers by Manjunath Ghate Breakdown of academic impact, for papers by Andrea Tafi Breakdown of academic impact, for papers by Xerardo García‐Mera Breakdown of academic impact, for papers by Rajani Giridhar Breakdown of academic impact, for papers by Antonio Carrieri
Rankless by CCL
2026